American Liver Foundation, our Partner in the Fight against PBC

 

As a result of the ALF PBC scientific meeting in 1998 a research agenda specifically addressing questions plaguing the understanding of PBC was established.

 

The PBC Fund for the Cure was initiated to develop resources for grants for targeted research in the area of Primary Biliary Cirrhosis.  Donations to the Fund are used to support research. 

 

The grants review process is comprehensive and highly competitive.  The review committee comprises many of the nation’s most noted researchers and clinicians in the field of liver research.  Grant applications are carefully assessed by committee members and must be rated at the highest level for grant consideration.  

 

In 1997-1998 donations by caring individuals, outside the PBC Fund for the Cure, was used for the PBC Research Agenda Development Meeting and seed grants for the following.

 

Year

Award Type

Amount

L name

F name

Institution

Title

1997

Study

   $50,000

 

 

 

PBC Research Agenda Development Meeting

1997

Postdoc

  $10,000

Lazaridis, MD

Konstantinos

Mayo Clinic, MN

Regulation and Physiologic Significance of the Ileal Na+ - Taurocholate

Cotransporting Polypeptide in Intrahepatic Bile Duct Epithelial Cells

 

 

1998

Seed

 $100,000

Gershwin,  MD

M. Eric

University of California, Davis

The Molecular Identification of Disease-Specific Molecules in PBC

 

 

1998

Seed

 $100,000

Mason, MBBS

Andrew L.

Ochsner Clinic, LA

A Pilot Study of Lamivudine Therapy for Patients with PBC

1998

Seed

 $100,000

Theise, MD

Neil D.

NY University Medical Center

Isolation and In Vitro Growth of Biopotent Progenitor Cells from Adult Human Livers

1998

Seed

 $100,000

Worman, MD

Howard J.

Columbia University, NY

Nuclear Envelope Protein Paralogues as Autoantigens in PBC

1998

Seed

 $100,000

Peters, MD

Marion G.

University of California, SF

Transgenic Murine Model of Biliary Specific Injury

 

 

1998

Postdoc

   $10,000

Feng, PhD

Li

Albert Einstein College of Medicine, NY

Cloning, Expression and Characterization of Recombinant Human Liver

Phosphatidycholine Transfer Protein

 

 

1999

Postdoc

   $10,000

Gong, MD

Aiyu

Mayo Clinic, MN

Aquaporin Channel-Mediated Transepithelial Water Movement in Isolated

Mouse Bile Duct Units

 

 

2000

Postdoc

   $10,000

Rumalla, MD

Ashwin

Mayo Clinic, MN

Distinguishing Benign and Malignant Scritcures of the Biliary

Tract Ploidy Assessment by Digital Image Analysis

 

 

2001

Postdoc

   $10,000

Pusl, MD

Thomas

Yale University School of Medicine

Regulation of Gene Expression in Liver by Ursodeoxycholic Acid

 

 

 

2002

Postdoc

   $10,000

Bohan, MD

Alan

Yale University School of Medicine

Role of the Nuclear Hormone Receptors Farnesoid X Receptor and

Retinoid X Receptor in the Transcriptional Regulation of Bile Salt

Metabolism and Transport in Obstructive Cholestasis

2003

-0-

 

 

 

 

 

  

2004

Postdoc

   $10,000

Mazzone, PhD

Amelia

Mayo Medical School

Hepatocyte Membrane Microdomain: A Role in Regulating Ductal Bile Secretion

 

2004

Seed

  $100,000

Lazaridis, MD

Konstantinos

Mayo Clinic and Foundation

Genetic Epidemiology of PBC

2005

 

 

 

 

 

 

Total

 

$720,000

   

 

 

 

2006

Joseph A. Odin, MD, PhD, Mount Sinai School of Medicine $200,000  Does Vitamin D Supplementation Enhance Immune Function in Primary Biliary Cirrhosis? (Over 2 years)

 

Carlo Selmi, MD, PhD, University of California, Davis $200,000  Epigenetics of X-Linked Genes in PBC: Does X Mark the Spot? (Over 2 years)

 

Keishi Kanno, MD, PhD, Brigham and Women’s Hospital received $12,500 over one year for Hosphatidylcholine Transfer Protein: Regulation of Hepatobiliary Lipid Metobolism by a START Domain

 

Ping P. Lam, PhD, Yale University School of Medicine received $12,500 over one year for Cellular and Functional Defects of the Liver Bile Salt Export Pump

 

Total                                $1,145,000

2007

Shi-Ying Cai, PhD, Yale University School of Medicine received $200,000 over 2 years for Ursodeoxyclolic Acid and Retinoic Acid Combination Treatment for Primary Biliary Cirrhosis

 

Total                                $1,345,000

Other funds have been disbursed by the National Institute of Health for additional research projects.

 

Research like this can provide the answers so desperately needed by patients who suffer from liver disease.   http://pbcers.org/donation.htm

 

Thank you.

Sandra (Tropple) Stoddard

PBCers Organization Executive Committee

 

 

 

BACK